Đang chuẩn bị liên kết để tải về tài liệu:
Blood Disorders in the Elderly - part 7

Tôi Yakoub-Agha, Attal M, Dumontet C, et al. Thalidomide trong bệnh nhân đa u tủy tiên tiến: một nghiên cứu 83 bệnh nhân báo cáo của Pháp ngữ Intergroupe du Myelome (IFM). Hematol J năm 2002; 3: 185-92. Palumbo A, Giaccone L, Bertola A, et al. Thalidomide cộng với dexamethasone liều thấp là một liệu pháp cứu hộ hiệu quả cho u tủy tiên tiến. | 288 Todd J. Alekshun Melissa Alsina after single-agent thalidomide identification of prognostic factors in a phase 2 study of 169 patients. Blood 2001 98 492-4. 88. Yakoub-Agha I Attal M Dumontet C et al. Thalidomide in patients with advanced multiple myeloma a study of 83 patients-report of the Inter-groupe Francophone du Myelome IFM . Hematol J 2002 3 185-92. 89. Palumbo A Giaccone L Bertola A etal. Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. Haematologica 2001 86 399-403. 90. Anagnostopoulos A Weber D Rankin K Delasalle K Alexanian R. Thalidomide and dexamethasone for resistant multiple myeloma. Br J Haematol 2003 121 768-71. 91. Kumar S Lacy MQ Dispenzieri A et al. High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy. Bone Marrow Transplant 2004 34 161-7. 92. Alexanian R Dimopoulos M. The treatment of multiple myeloma. N Engl J Med 1994 330 484-9. 93. DaltonWS Hazlehurst L Shain K Landowski T Alsina M. Targeting the bone marrow microenvironment in hematologic malignancies. Semin Hematol 2004 41 2 Suppl 4 1-5. 94. Damiano JS Hazlehurst LA Dalton WS. Cell adhesion-mediated drug resistance CAM-DR protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR ABL inhibition cytotoxic drugs and gamma-irradiation. Leukemia 2001 15 1232-9. 95. Mudry RE Fortney JE York T Hall BM Gibson LF. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000 96 1926-32. 96. Andela VB Schwarz EM Puzas JE O Keefe RJ Rosier RN. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 2000 60 6557-62. 97. Huang Y Johnson KR Norris JS Fan W. Nuclear factor-kappaB IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res 2000 60 4426-32. 98. Kim JY Lee S Hwangbo B et al. NF-kappaB .